WO1996036330A3 - Compositions containing fatty acids for improving digestion and absorption in the small intestine - Google Patents
Compositions containing fatty acids for improving digestion and absorption in the small intestine Download PDFInfo
- Publication number
- WO1996036330A3 WO1996036330A3 PCT/US1996/007165 US9607165W WO9636330A3 WO 1996036330 A3 WO1996036330 A3 WO 1996036330A3 US 9607165 W US9607165 W US 9607165W WO 9636330 A3 WO9636330 A3 WO 9636330A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- absorption
- small intestine
- fatty acids
- compositions containing
- containing fatty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8535091A JPH11505258A (en) | 1995-05-17 | 1996-05-16 | Compositions comprising fatty acids that improve digestion and absorption in the small intestine |
EP96920275A EP0827402A2 (en) | 1995-05-17 | 1996-05-16 | Compositions containing fatty acids for improving digestion and absorption in the small intestine |
AU58629/96A AU722133C (en) | 1995-05-17 | 1996-05-16 | Compositions containing fatty acids for improving digestion and absorption in the small intestine |
BR9608795A BR9608795A (en) | 1995-05-17 | 1996-05-16 | Compositions containing fatty acids to improve digestion and absorption in the small intestine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42284395A | 1995-05-17 | 1995-05-17 | |
US44284395A | 1995-05-17 | 1995-05-17 | |
US08/442,843 | 1995-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996036330A2 WO1996036330A2 (en) | 1996-11-21 |
WO1996036330A3 true WO1996036330A3 (en) | 1997-05-22 |
Family
ID=27025783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/007165 WO1996036330A2 (en) | 1995-05-17 | 1996-05-16 | Compositions containing fatty acids for improving digestion and absorption in the small intestine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1996036330A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
CA2201855C (en) | 1995-08-07 | 2008-11-18 | Satomichi Yoshimura | Preventive or remedy for diseases caused by abnormalities in cartilage tissues |
WO1999017766A1 (en) * | 1997-10-03 | 1999-04-15 | Warner-Lambert Company | Compressed nitroglycerin tablet and its method of manufacture |
DE10006836B4 (en) * | 2000-04-18 | 2005-03-24 | Bitec Gmbh | Use of omega-3 fatty acids and / or compounds of omega-3 fatty acids |
WO2001082979A1 (en) * | 2000-05-02 | 2001-11-08 | Otsuka Pharmaceutical Co., Ltd. | Preparations for evaluating eliminative ability of stomach |
JP5178195B2 (en) | 2005-07-25 | 2013-04-10 | 大塚製薬株式会社 | Oral preparations useful for measuring pyridine metabolic capacity |
CA2821770A1 (en) | 2010-12-29 | 2012-07-05 | Abbott Laboratories | Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child |
JP6352188B2 (en) | 2012-08-20 | 2018-07-04 | 大塚製薬株式会社 | Method for measuring sugar metabolic capacity and composition used therefor |
WO2014142248A1 (en) | 2013-03-15 | 2014-09-18 | 大塚製薬株式会社 | Method of measuring insulin resistance with fatty acid combustion, and composition used herein |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0200902A2 (en) * | 1985-03-26 | 1986-11-12 | Fujisawa Pharmaceutical Co., Ltd. | Drug carrier and pharmaceutical preparation comprising it |
EP0539319A2 (en) * | 1991-06-27 | 1993-04-28 | Sandoz Ltd. | Pharmaceutical cyclosporin composition |
-
1996
- 1996-05-16 WO PCT/US1996/007165 patent/WO1996036330A2/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0200902A2 (en) * | 1985-03-26 | 1986-11-12 | Fujisawa Pharmaceutical Co., Ltd. | Drug carrier and pharmaceutical preparation comprising it |
EP0539319A2 (en) * | 1991-06-27 | 1993-04-28 | Sandoz Ltd. | Pharmaceutical cyclosporin composition |
Non-Patent Citations (13)
Title |
---|
BROWN NJ ET AL: "Characteristics of lipid substances activating the ileal brake in the rat.", GUT, OCT 1990, 31 (10) P1126-9, ENGLAND, XP000613253 * |
DREZNIK Z ET AL: "Effect of ileal oleate on interdigestive intestinal motility of the dog.", DIG DIS SCI, JUL 1994, 39 (7) P1511-8, UNITED STATES, XP000613256 * |
HUGE, A. ET AL: "Effects of enteral feedback inhibition on motility, luminal flow, and absorption of nutrients in proximal gut of minipigs", DIGESTIVE DISEASES AND SCIENCES, vol. 40, no. 5, May 1995 (1995-05-01), pages 1024 - 34, XP000613720 * |
LIN, H.C. ET AL: "Jejunal brake inhibition of small intestinal transit by fat in the proximal small intestine", DIGESTIVE DISEASES AND SCIENCES, vol. 41, no. 2, February 1996 (1996-02-01), pages 326 - 329, XP000613235 * |
OHTANI N ET AL: "Mediators for ileal brake differ between the stomach and small intestine in conscious dogs", GASTROENTEROLOGY, 108 (4 SUPPL.). 1995. A660., XP000613262 * |
PIRONI L ET AL: "Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY.", GASTROENTEROLOGY, SEP 1993, 105 (3) P733-9, UNITED STATES, XP000613255 * |
READ, N.W. ET AL: "Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucan", GASTROENTEROLOGY, vol. 86, no. 2, 1984, pages 274 - 280, XP000613231 * |
SAUNDERS DR ET AL: "Absorption of triglyceride by human small intestine: dose-response relationships.", AM J CLIN NUTR, OCT 1988, 48 (4) P988-91, UNITED STATES, XP000613273 * |
SIEGLE ML ET AL: "Effects of ileal infusions of nutrients on motor patterns of canine small intestine.", AM J PHYSIOL, JUL 1990, 259 (1 PT 1) PG78-85, UNITED STATES, XP000613360 * |
SOPER NJ ET AL: "The 'ileal brake' after ileal pouch-anal anastomosis.", GASTROENTEROLOGY, JAN 1990, 98 (1) P111-6, UNITED STATES, XP000613254 * |
SPILLER, R.C. ET AL: "Further characterization of the "ileal brake" reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucan, and peptide YY", GUT, vol. 29, no. 8, 1988, pages 1942 - 1051, XP000613225 * |
SPILLER, R.C. ET AL: "The ileal brake- inhibition of jejunal motility after ileal fat perfusion in man", GUT, vol. 25, no. 4, 1984, pages 365 - 374, XP000613230 * |
ZHOU, X.T. ET AL: "Fat in distal gut inhibits intestinal transit more potently than fat in proximal gut", GASTROENTEROLOGY, vol. 108, no. 4, April 1995 (1995-04-01), pages A714, XP000613263 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996036330A2 (en) | 1996-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9708858A (en) | Compositions containing fatty acids for improving digestion and absorption in the small intestine. | |
BG103793A (en) | COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS | |
ZA200200259B (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents. | |
CA2274596A1 (en) | Compositions and methods for enhancing intestinal function | |
RU94028653A (en) | Pharmaceutical preparation | |
EP1045636A4 (en) | Pharmaceutical compositions and methods for the treatment of failing myocardial tissue | |
CA2341973A1 (en) | Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid | |
MY120984A (en) | Activated protein c formulations | |
WO1997044063A3 (en) | Dha-pharmaceutical agent conjugates | |
IL112667A (en) | 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them | |
MX9709238A (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders. | |
PL373903A1 (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease | |
IL112664A0 (en) | 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them | |
CA2244512A1 (en) | Dietary supplements containing natural ingredients | |
AU6257798A (en) | Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase | |
CA2159058A1 (en) | Inhibition of helicobacter | |
AU2470299A (en) | Combinations of tyrosine, methylating agents, phospholipids, fatty acids, and st. john's wort for the treatment of mental disturbances | |
DE69624354D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF PROTEINASE AND A MONOGLYCERIDE | |
CA2270177A1 (en) | Transdermal administration of ment | |
WO1996036330A3 (en) | Compositions containing fatty acids for improving digestion and absorption in the small intestine | |
CA2253130A1 (en) | A medicament for treating obesity and improving lipid metabolism | |
TW325996B (en) | Anti-atherosclerotic composition containing 17α-dihydroequilin | |
GB2379855A (en) | Dietary regime for companion animals | |
HK1018211A1 (en) | Pharmaceutical combination preparation of an inhibitor of the sodium/dydrogen exchanger and a medicament for the treatment of cardiovascular diseases. | |
CA2201855A1 (en) | Preventive or remedy for diseases caused by abnormalities in cartilage tissues |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
ENP | Entry into the national phase |
Ref document number: 2220451 Country of ref document: CA Ref country code: CA Ref document number: 2220451 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 535091 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970708210 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996920275 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996920275 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970708210 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970708210 Country of ref document: KR |